Your browser doesn't support javascript.
loading
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma.
Squifflet, Pierre; Michiels, Stefan; Siegel, David; Vij, Ravi; Jagannath, Sundar; Saad, Everardo D; Rajangam, Kanya; Ro, Sunhee Kwon; Buyse, Marc.
Afiliação
  • Squifflet P; International Drug Development Institute, Louvain-la-Neuve, Belgium. Electronic address: pierre.squifflet@iddi.com.
  • Michiels S; Service de Biostatistique et d'Epidémiologie, Institut Gustave Roussy, Université Paris-Sud, Villejuif, France.
  • Siegel D; John Theurer Cancer Center at Hackensack University, Hackensack, NJ.
  • Vij R; Washington University School of Medicine, St Louis, MO.
  • Jagannath S; Mount Sinai Medical Center, New York, NY.
  • Saad ED; International Drug Development Institute, Louvain-la-Neuve, Belgium; Dendrix Research, Sao Paulo, Brazil.
  • Rajangam K; Onyx Pharmaceuticals, Inc, An Amgen subsidiary, South San Francisco, CA.
  • Ro SK; Onyx Pharmaceuticals, Inc, An Amgen subsidiary, South San Francisco, CA.
  • Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium.
Clin Lymphoma Myeloma Leuk ; 15(11): 680-6, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26482107
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Inibidores de Proteassoma / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Inibidores de Proteassoma / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article